Celyad is a biopharmaceutical company, specialized in cell therapy and developing of technologies to treat severe diseases with poor prognosis. The Company focuses on immuno oncology, cardiology, and medical devices.

Type
Public
HQ
Mont-Saint-Guibert, BE
Founded
2007
Size (employees)
79 (est)-3%
Website
celyad.com
Celyad was founded in 2007 and is headquartered in Mont-Saint-Guibert, BE
Report incorrect company information

Key People/Management at Celyad

Christian Homsy

Christian Homsy

Executive Director, CEO
Patrick Jeanmart

Patrick Jeanmart

CFO, Investor Relations
Jean-Pierre Latere

Jean-Pierre Latere

Chief Operating Officer (COO)
Frederic Lehmann

Frederic Lehmann

VP Clinical Development and Medical Affairs
David Gilham

David Gilham

VP Research & Development
Philippe Dechamps

Philippe Dechamps

Chief Legal Officer
Show more

Celyad Office Locations

Celyad has offices in Mont-Saint-Guibert and Boston
Mont-Saint-Guibert, BE (HQ)
2 Rue Edouard Belin
Boston, US
2 Seaport Ln
Show all (2)
Report incorrect company information

Celyad Financials and Metrics

Celyad Financials

Market capitalization (22-Mar-2017)

190.4 b

Closing share price (22-Mar-2017)

20.2
Celyad's current market capitalization is €190.4 b.
Show all financial metrics
Report incorrect company information